Board Meeting Outcome for The Meeting Held Today I.E., Saturday, 17Th October, 2026
Filed with BSE · · 7 pages · English
Summary by 6ix AI
Hemo Organic Limited has reported the outcome of its board meeting held on a recent date, where the board approved the unaudited standalone financial results for the quarter and half-year ended in September of the current year. The financial results were prepared in accordance with relevant regulations and include a limited review report from the statutory auditors. The filing also notes that the company operates in a single segment and provides details on the preparation of its financial results.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Hemo Organic
- Board Meeting Intimation for The Meeting To Be Held On Saturday, I.E., 17Th October, 2026
- Withdrawal Of Consent To Act As Company Secretary And Compliance Officer
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Appointment of Company Secretary and Compliance Officer
Later from Hemo Organic
- Submission Of Un-Audited Financial Results Along With Limited Review Report Thereon For The Quarter And Half Year Ended 30Th September, 2026
- Statement On Deviation(S) / Variation(S) In Utilization Of Proceeds Raised Through Preferential Issue Of Convertible Warrants, Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations) For The Quarter Ended On September 3
Follow Hemo Organic into a list and get an email when it puts out news.
Follow Hemo Organic